Online ISSN: 3007-0244,
Print ISSN:  2410-4280
Relevance. Over the past decades, increasingly used tools to measure the life quality of BPH patients. Aim. This study evaluated some risk factors of the Kazakh population for the analysis of benign prostatic hyperplasia in Semey, East-Kazakhstan region. Three types of risk factors such as prostate volume, glomerular filtration rate, age have been studied. Materials and methods. 812 benign prostatic hyperplasia patients were carried out. These patients were recruited from clinical Kidney Centre. The study subjects were divided on the basis of Age groups, PV groups and GFR groups. To determine the normal distribution of statistical data, we used the Shapiro-Wilk Test. The confidence interval was calculated using the Wald method. Results. The average age of patients with BPH was 68.4 ± 15.7 years. Also in our study, we found that the mean PV for all patients was 45.4 ml. This was in accordance with that of Kazakh population. Mean prostate volume of BPH patients in Glomerular filtration rate groups was found to be 45.4±9.38 ml/min (p=0.003). PV was found to be higher in group with reduced glomerular filtration rate. Conclusion. Prostate gland volume of patients increased significantly with increasing age. Lower Glomerular Filtration Rate is dependent risk factor for prostatic growth.
Asset M. Kussainov1, 0000-0002-8816-5357 Ainash B. Salmenbaeva1, Malika E. Musulmanbek1, Tolkyn A. Bulegenov1, 0000-00016145-9649 Nazarbek B. Omarov1, 0000-0002-6201-8263 Kuat D. Akimzhanov1, 0000-0002-8608-0771 Muratkan Т. Kuderbayev1, Vladimir B. Kolyado6 1 NСJSC «Semey Medical University», Department of Surgical Dissociations, Semey, Republic of Kazakhstan; 2 City Hospital №1, Semey, Republic of Kazakhstan; 3 NСJSC «Semey Medical University», Department of neurology, ophthalmology and otorhinolaryngology, Semey, Republic of Kazakhstan; 4 NСJSC «Semey Medical University», Department of Hospital and Pediatric Surgery, Semey, Republic of Kazakhstan; 5 University Hospital NСJSC «Semey Medical University», Semey, Republic of Kazakhstan; 6 «Altai State Medical University» Ministry of health of the Russian Federation, Barnaul city, Russian Federation.
1. Agrawal C., Chalise P., Bhandari B. Correlation of prostate volume with international prostate symptom score and quality of life in men with benign prostatic hyperplasia // Nepal Medical College journal: NMCJ. 2008. 10:2:104-7. 2. Albisini Simone, Fouad Aoun, Thierry Roumeguere, Francesco Porpiglia, Andrea Tubaro. New treatment strategies for benign prostatic hyperplasia in the frail elderly population: a systematic review // Minerva Urologica e Nefrologica.2017. April.69(2).pp.19-32 3. Burke J.P., Rhodes T., Jacobson D.J., McGree M., et al. Association of anthropometric measures with the presence and progression of benign prostatic hyperplasia // American Journal of Epidemiology, 2006. 164:1:41-6. 4. Chokkalingam A.P., Gao Y.T., Deng J., Stanczyk F.Z., Sesterhenn I.A., Mostofi F. et al. Insulin‐like growth factors and risk of benign prostatic hyperplasia // The Prostate. 2002.52:2:98-105. 5. Giovannucci E., Rimm E.B., Chute C.G., Kawachi I., et al. Obesity and benign prostatic hyperplasia // American journal of epidemiology. 1994. 140:11:989-1002. 6. Habes M., Bahr J., Schiller T., Kühn J.P., Hoppe L., et al. New technique for prostate volume assessment // World Journal of Urology. 2014. 32(6):1559-69. 7. Han X.F., Ren J.L., Hu L.M., Chen F.R., Xu K.X. Prevalence of benign prostatic hyperplasia in Pingliang. Gansu: investigation and clinical analysis Zhonghua Nan Ke Xue. 2013. 19:4:324-327. 8. Hoo N.K., Ayob M.A., et al. Prostate Volume Ultrasonography: The Relationship of Body Weight, Height, Body Mass Index and Ethnicity in Transabdominal Measurement // International Journal of Biology and Biomedical Engineering. 2012. 4:6:187-95. 9. Jayadevappa R., Chhatre S., Johnson J.C., Malkowicz S.B. Association between ethnicity and prostate canceroutcomes across hospital and surgeon volume groups // Health policy. 2011.99:2:97-106. 10. Kim J., Shim S., Lee W., Kim H., Kwon S.S., Bae J. Sociodemographic and lifestyle factors affecting the self‐perception period of lower urinary tract symptoms of international prostate symptom score items // International journal of clinical practice. 2012.66:12:1216-23. 11. Kok E.T., Schouten B.W., Bohnen A.M., Groeneveld F.P., Thomas S., Bosch J.L. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen study // Journal Urology. 2009. 181:710-6. 12. Lee S., Min H.G., Choi S.H., Kim Y.J., Oh S.W., Kim Y.J., et al. Central obesity as a risk factor for prostatic hyperplasia // Obesity. 2006. 14:1:172- 11. 13. Lee S.W.H., Chan E.M.C., Lai Y.K. The global burden of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A systematic review and meta-analysis. 2017 Aug 11. 7(1):7984. doi: 10.1038/s41598-017-06628-8. 14. McVary K.T. Benign prostatic hyperplasia 1-st ed. Humana Press Inc: Totowa NJ, 2004. P.21-33. 15. McVary K.T., Roehrborn C.G., Avins A.L., Barry M.J., Bruskewitz R.C., Donnell R.F. et al. Update on AUA guideline on the management of benign prostatic hyperplasia // The Journal of urology. 2011. 185:5:1793- 803. 16. Mosli H., Abdel-Meguid T.A. The relationship between prostate volume, prostate-specific antigen and age in Saudi men with benign prostatic conditions // African Journal of Urology. 2010.16:4:117-23. 17. Ochiai A., Fritsche H.A., Babaian R.J. Influence of anthropometric measurements, age, and prostate volume on prostate-specific antigen levels in men with a low risk of prostate cancer // Urology. 2005. 66 (4):819-23. 18. Parsons J.K., Carter H.B., Partin A.W., Windham B.G., Metter E.J., Ferrucci L. et al. Metabolic factors associated with benign prostatic hyperplasia // The Journal of Clinical Endocrinology & Metabolism 2006;91;7:2562-8. 19. Placets E.A., Kavachi I., Rimm E.B., Willett V.K., Giovannucci E. Race. Еthnicity and benign prostatic hyperplasia in a subsequent study of health workers // J Urol.2000. 163. Pp. 490–495. 20. Platz E.A., Kawachi I., Rimm E.B., Willett W.C., Giovannucci E. Race, ethnicity and benign prostatic hyperplasia in the health professionals follow up study // Journal Urology. 2000.163:490-5. 21. Rohrmann S., Smit E., Giovannucci E., Platz E.A. Associations of obesity with lower urinary tract symptoms and noncancer prostate surgery in the Third National Health and Nutrition Examination Survey // American Journal of Epidemiology. 2004.159:4:390-7. 22. Seim A., Hoyo C., Ostbye T., Vatten L. The prevalence and correlates of urinary tract symptoms in Norwegian men: the HUNT study // BJU international. 2005. 96:1:88-96. 23. Sorkin J.D., Muller D.C., Andres R. Longitudinal change in height of men and women: implications for interpretation of the body mass index: the Baltimore Longitudinal Study of Aging // American Journal of Epidemiology. 1999. 150:9:969-77. 24. Standring S., Healy J., Johnson D., Williams A., Standring S. Gray’s Clinical Anatomy ed 40th.. London Elsevier: Churchill Livingstone 2008; 25. Vuichoud C., Loughlin K.R. Benign Prostatic Hyperplasia: epidemiology, economics and evaluation // Can J Urol. 2015. 22 (Suppl 1). pp:1-6.
Количество просмотров: 5191

Ключевые слова:

Библиографическая ссылка

Kussainov A.M., Salmenbaeva A.B., Musulmanbek M.E., Bulegenov T.A., Omarov N.B., Akimzhanov K.D., Kuderbayev M.Т., Kolyado V.B. The influence of important risk factors on the incidence of benign prostatic hyperplasia in the population of Kazakhstan // Nauka i Zdravookhranenie [Science & Healthcare]. 2023, (Vol.25) 4, pp. 127-132. doi 10.34689/SH.2023.25.4.015

Авторизируйтесь для отправки комментариев